Impulse Dynamics vs Revvity
Side-by-side comparison of AI visibility scores, market position, and capabilities
Impulse Dynamics makes the Optimizer Smart Mini, the first FDA-approved device for Cardiac Contractility Modulation (CCM) therapy in NYHA Class III heart failure patients; conducting AIM HIGHer RCT targeting expanded indication (LVEF 40–60%).
About
Impulse Dynamics is a medical device company founded in 1996 that developed and commercialized Cardiac Contractility Modulation (CCM®) therapy — a proprietary approach to treating chronic heart failure that is distinct from pacemakers, ICDs, or cardiac resynchronization therapy (CRT). CCM therapy delivers precisely timed, high-energy electrical signals to the right ventricle during the absolute refractory period, when the heart cannot be paced. These signals do not alter heart rhythm but instead improve the contractile force of cardiac muscle — addressing the fundamental mechanical impairment of heart failure.
Revvity (RVTY) reported ~$2.9B revenue in FY2024. Life science tools and diagnostics company providing instruments, reagents, and software for genomics, newborn screening, and drug discovery. HQ: Waltham, MA.
About
Revvity, Inc. (formerly PerkinElmer) is a global life science tools and diagnostics company, rebranded in 2023 to signal its transformation from a diversified instruments company into a focused provider of solutions for reproductive health, genomics, and applied markets. The company operates in two segments: Life Sciences (analytical instruments, reagents, software for pharmaceutical and academic research) and Diagnostics (immunoassay and molecular diagnostic systems for clinical and screening applications). Revvity is the global leader in newborn screening, processing the tests that check newborns for metabolic and genetic disorders shortly after birth.
Key Details
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.